Interpretability of PET/CT imaging in head and neck cancer patients following composite mandibular resection and osteocutaneous free flap reconstruction

Head and Neck

Volumn 30, Issue 2, 2008, Pages 187-193

  Oliver, Christopher ^a   Muthukrishnan, Ashok ^b   Mountz, James ^b   Deeb, Erin ^b   Johnson, Jonas ^b   Deleyiannis, Frederic ^b  

^a University of Pittsburgh School of Medicine   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Head and neck neoplasms; Neoplasm; Neoplasm recurrence; Positron emission tomography; Residual; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MANDIBLE RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCUTANEOUS FLAP; OSTEOTOMY; PLASTIC SURGERY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MANDIBLE; MIDDLE AGED; OSTEOTOMY; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGICAL FLAPS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39149113137     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20677     Document Type: Article

References (23)

1. Schelstraete K, Simons M, Deman J, et al. Uptake of 13N-ammonia by human tumours as studied by positron emission tomography. Br J Radiol 1982;55:797-804.
2. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379.
3. Branstetter BFt, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005;235:580-586.
4. Zimmer LA, Branstetter BF, Nayak JV, Johnson JT. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope 2005;115:2029-2034.
5. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933-941.
6. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography. Laryngoscope 1999;109:970-975.
7. Ryan WR, Fee WE Jr, Le QT, Pinto HA. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-650.
8. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fiuoro- D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141.
9. Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-658.
10. Lonneux M, Lawson G, Ide C, Bausart R, Remade M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000;110:1493-1497.
11. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
12. Fischbein NJ, OS AA, Caputo GR, et al. Clinical utility of positron emission tomography with 18F-fluorodeoxy-glucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1998;19:1189-1196.
13. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 1997;22:209-214.
14. Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck, Part 1: Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics 2005;25:897-912.
15. Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ. Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer. Laryngoscope 2006;116:705-710.
16. Schoder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged NO by clinical examination and CT/MRI. J Nucl Med 2006;47:755-762.
17. Fakhry N, Jacob T, Paris J, et al. [Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor]. Ann Otolaryngol Chir Cervicofac 2006;123:17-25.
18. Johansen J, Eigtved A, Buchwald C, Theilgaard SA, Hansen HS. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002;112:2009-2014.
19. Kennedy JA, Israel O, Frenkel A, Bar-Shalom R, Azhari H. Super-resolution in PET imaging. IEEE Trans Med Imaging 2006;25:137-147.
20. Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 2003;30:1096-1103.
21. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003;28:171-175.
22. Zhuang H, Chacko TK, Hickeson M, et al. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur J Nucl Med Mol Imaging 2002;29:1328-1333.
23. Goerres GW, Schmid DT, Eyrich GK. Do hardware artefacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer? Dentomaxillofac Radiol 2003;32:365-371.